Corey, L <br/><br/>
Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.  [electronic resource] 

 -  The Journal of infectious diseases  Feb 1998 
 - 301-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1086/514202  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--immunology<br/>Adolescent<br/>Adult<br/>Antibodies, Blocking--immunology<br/>Antibodies, Viral--analysis<br/>Antibody Affinity--immunology<br/>CD4 Antigens--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cytotoxicity Tests, Immunologic<br/>Double-Blind Method<br/>Female<br/>HIV Antibodies--analysis<br/>HIV Antigens--genetics<br/>HIV Envelope Protein gp120--genetics<br/>HIV Envelope Protein gp160--genetics<br/>HIV Infections--genetics<br/>HIV-1--genetics<br/>Humans<br/>Male<br/>Middle Aged<br/>Neutralization Tests<br/>Recombinant Proteins--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Vaccines, Combined--immunology<br/>Vaccines, Synthetic--immunology<br/>Vaccinia virus--genetics